Team finds broken 'brake' on cancer mutation machine.

Published Date: 09 Aug 2023

According to a group led by UT Southwestern Medical, loss of the SYNCRIP gene in prostate cancer tumors unleashes cellular machinery that leads to random mutations throughout the genome that increase resistance to targeted therapies.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

2.

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

3.

New tumor therapy approach reduces costs and side effects while increasing accessibility

4.

CAR T cells improve patients' quality of life: a study

5.

A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot